Ultra-Sensitive Immunoassay Test for Quantitation of SARS-CoV-2 Antigen
收藏DataCite Commons2026-03-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012580/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Background: The 5534 prospective clinical study sought to examine the performance of the 5534 device for the detection of SARS-CoV-2 nucleocapsid protein antigen compared to the Roche 6800 Cobas PCR for SARS-CoV-2 assay.
Materials/Methods: The Simoa SARS-CoV-2 N Protein Antigen Test was tested for sensitivity and specificity in the detection of SARS-CoV-2 nucleocapsid protein antigen in the acute phase of infection.
Outcome/Impact: The study outcome allowed for the Emergency Use Authorization (EUA) approval for the device to use among symptomatic persons by trained healthcare personnel collecting nasal, saliva, and dried blood spot samples.
提供机构：
Vivli
创建时间：
2026-01-09
